Counseling in teratogenicity. the case of pregnant women with crohn’s disease.

• In: Pharmacy Information - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: PI-P-008
• By: RIBEIRO RAMA, Ana Cristina (Coimbra University Hospitals, Pharmacy, Coimbra, Portugal)
• Co-author(s): Barbosa, Renata (Coimbra University Hospitals, Pharmacy, Portugal)
  Isabel, Odete (Coimbra University Hospitals, Pharmacy, Portugal)
  Zagalo Cardoso, Jose (Coimbra University Hospitals, Medical Genetics Service, Portugal)
  Tavares Silva, Francisco (Coimbra University Hospitals, Medical Genetics Service, Portugal)
  Almeida Santos, Ana Teresa (Coimbra University Hospitals, Medical Genetics Service, Portugal)
  Silva, Cristina (Faculty Pharmacy University Oporto, Portugal)
  Fernandez-Llimos, Fernando (Faculty Pharmacy University Lisbon, Portugal)
  Figueiredo, Isabel Vitoria (Faculty Pharmacy University Coimbra, Portugal)
  Caramona, Maria Margarida (Faculty Pharmacy University Coimbra, Portugal)
  
• Abstract:

  The use of medication by women during their reproductive life span raises problems concerning possible effects. Several situations like, exposition to medicines with unknown teratogenic effect before or after conception, agents of choice to treat acute or chronic disease coexisting with pregnancy or even their use for foetal therapy, require a..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login